Norrie Disease (Pseudoglioma) anticorps
Aperçu rapide pour Norrie Disease (Pseudoglioma) anticorps (ABIN6263552)
Antigène
Voir toutes Norrie Disease (Pseudoglioma) (NDP) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- NDP Antibody detects endogenous levels of total NDP
-
Réactivité croisée
- Humain, Souris, Rat (Rattus)
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human NDP
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000 IHC 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C.Stable for 12 months from date of receipt
-
Date de péremption
- 12 months
-
-
- Norrie Disease (Pseudoglioma) (NDP)
-
Autre désignation
- NDP
-
Sujet
-
Description: Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction.
Gene: NDP
-
Poids moléculaire
- 15kDa
-
ID gène
- 4693
-
UniProt
- Q00604
-
Pathways
- Sensory Perception of Sound
Antigène
-